Advertisement
Products > All
Please find below all kinds of products and services related to organisations from the United Kingdom (Great Britain) and the Republic of Ireland i.e., the “product portfolio” of these regions.Total search results: 2547 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26
Product | Product Group | Organisation | Date |
---|---|---|---|
Humicade | TNF antibody | UCB (Group) | 1996-02-29 |
CellCept® | immuno modulatory compound (IMO)_o | Roche (Group) | 1996-02-14 |
Bricanyl® | bronchospasmolytics & asthma drugs_o | AstraZeneca (Group) | 1996-01-01 |
Campto® | topoisomerase inhibitor | Pfizer (Group) | 1996-01-01 |
Cleocin® | anti-infective drug_o | Pfizer (Group) | 1996-01-01 |
Coreg® | beta-receptor blocker | GSK (Group) | 1996-01-01 |
Depo-Provera® | Pfizer (Group) | 1996-01-01 | |
Epivir® | virostatic agent | GSK (Group) | 1996-01-01 |
Faslodex | Antiöstrogen (qm) | 1996-01-01 | |
Glynase® | antidiabetic_o | Pfizer (Group) | 1996-01-01 |
Human Gene Mutation Database (HGMD) (Qiagen/Biobase/Cardiff Univ) | genomic database | Cardiff University | 1996-01-01 |
Imdur® | Nitrate/Nitrite | AstraZeneca (Group) | 1996-01-01 |
Kredex® | beta-receptor blocker | GSK (Group) | 1996-01-01 |
Marcaine® | Lokalanästhetika / Neuraltherapeutika_s (qm) | AstraZeneca (Group) | 1996-01-01 |
Micronase® | antidiabetic_o | Pfizer (Group) | 1996-01-01 |
Panadol® | analgesic_o | GSK (Group) | 1996-01-01 |
patient management program (service) | health services | Bayer (Group) | 1996-01-01 |
Platform LC single quadrupole mass spectrometer (Micromass/Waters) | single quadrupole mass spectrometer | Waters (Group) | 1996-01-01 |
ProstaScint® | contrast medium / imaging agent | Jazz Pharmaceuticals (Group) | 1996-01-01 |
Pulmicort® | glucocorticoid | AstraZeneca (Group) | 1996-01-01 |
Q-TOF mass spectrometer (Micromass/Waters) | hybrid mass spectrometer | Waters (Group) | 1996-01-01 |
Relafen® | non-steroidal anti-inflammatory drug | GSK (Group) | 1996-01-01 |
Relifex® | non-steroidal anti-inflammatory drug | GSK (Group) | 1996-01-01 |
Rhinocort® | glucocorticoid | AstraZeneca (Group) | 1996-01-01 |
Seloken® | beta-receptor blocker | 1996-01-01 | |
Tums® | gastrointestinal drug_o | GSK (Group) | 1996-01-01 |
Xalatan® | ophthalmic_o | Pfizer (Group) | 1996-01-01 |
Taxotere® | taxane | Sanofi (Group) [since May 2011] | 1995-11-27 |
Gonal-F | anterior pituitary lobe hormone or analogue | Merck (DE) (Group) | 1995-10-20 |
Caverject® | urological drug_o | Pfizer (Group) | 1995-01-01 |
Diprivan® | Hypnotica / Sedativa_s (qm) | AstraZeneca (Group) | 1995-01-01 |
FluMist® | vaccine, influenza | AstraZeneca (Group) | 1995-01-01 |
Imuran® | immunologic modifier | GSK (Group) | 1995-01-01 |
Kompact MALDI IV mass spectrometer | time-of-flight mass spectrometer (TOF-MS) | Shimadzu (Group) | 1995-01-01 |
Medrol® | pharmaceutical_oo | Pfizer (Group) | 1995-01-01 |
Merrem® | antibiotic | 1995-01-01 | |
Pylorid® | H2 receptor antagonist | GSK (Group) | 1995-01-01 |
Rebif® | cytokine | Merck (DE) (Group) | 1995-01-01 |
Retrovir® | virostatic agent | GSK (Group) | 1995-01-01 |
Somatuline® | hormone analogue | Ipsen (Group) | 1995-01-01 |
Wellbutrin® | antidepressant | GSK (Group) | 1995-01-01 |
Zestril® | ACE inhibitor (class 3) | AstraZeneca (Group) | 1995-01-01 |
Zyloric® | Gichtmittel_s | GSK (Group) | 1995-01-01 |
Amphocil® | antimycotic | AstraZeneca (Group) | 1994-07-01 |
CFTR gene | pharmaceutical_oo | GSK (Group) | 1994-07-01 |
Distavax | vaccine_o | Sanofi (Group) [since May 2011] | 1994-07-01 |
Sempera® | antimycotic | GSK (Group) | 1994-04-01 |
Tracrium® | muscle relaxant_o | GSK (Group) | 1994-04-01 |
Adderall | psychopharmaceutical | Takeda (Group) | 1994-01-01 |
Botox® | muscle relaxant_o | 1994-01-01 | |
Famciclovir-SB® | virostatic agent | GSK (Group) | 1994-01-01 |
Famvir® | virostatic agent | GSK (Group) | 1994-01-01 |
Havrix® | vaccine, hepatitis | GSK (Group) | 1994-01-01 |
Irtan® | pharmaceutical_oo | Sanofi (Group) [since May 2011] | 1994-01-01 |
Ivias® | pharmaceutical_oo | Sanofi (Group) [since May 2011] | 1994-01-01 |
Kompact MALDI I mass spectrometer | time-of-flight mass spectrometer (TOF-MS) | Shimadzu (Group) | 1994-01-01 |
Pacis | cancer vaccine | Takeda (Group) | 1994-01-01 |
Panorex® | MAb | GSK (Group) | 1994-01-01 |
Quattro II mass spectrometer (Micromass) | triple quadrupole mass spectrometer | Waters (Group) | 1994-01-01 |
Wellvone® | anti-infective drug_o | GSK (Group) | 1994-01-01 |
Flixotide® | pharmaceutical_oo | GSK (Group) | 1993-01-01 |
Platform II single quadrupole mass spectrometer (Micromass/Waters) | single quadrupole mass spectrometer | Waters (Group) | 1993-01-01 |
Platform single quadrupole mass spectrometer (Micromass/Waters) | single quadrupole mass spectrometer | Waters (Group) | 1993-01-01 |
TwinsUK Registry | clinical research | University of London | 1993-01-01 |
Albenza® | anthelmint(h)ic_o | GSK (Group) | 1992-08-06 |
Nolvadex | Antiöstrogen (qm) | Imperial Chemical Industries (ICI) (Group) | 1992-07-01 |
Zovirax® | virostatic agent | GSK (Group) | 1992-07-01 |
Imigran® | serotonin agonist | GSK (Group) | 1992-01-01 |
Kompact MALDI II mass spectrometer | time-of-flight mass spectrometer (TOF-MS) | Shimadzu (Group) | 1992-01-01 |
Kompact MALDI III mass spectrometer | time-of-flight mass spectrometer (TOF-MS) | Shimadzu (Group) | 1992-01-01 |
Metastron | RADIOPHARMACEUTICAL (RPT) | General Electric (Group) | 1992-01-01 |
Paxil® | antidepressant | GSK (Group) | 1992-01-01 |
Proventil® | pharmaceutical_oo | GSK (Group) | 1992-01-01 |
Seroxat® | antidepressant | GSK (Group) | 1992-01-01 |
TOF Spec mass spectrometer | time-of-flight mass spectrometer (TOF-MS) | Waters (Group) | 1992-01-01 |
Didronel® | biphosphonate | Procter & Gamble (P&G) (Group) | 1991-11-01 |
Bambec® | bronchospasmolytics & asthma drugs_o | AstraZeneca (Group) | 1991-01-01 |
Belosorb® | calcium channel blocker | AstraZeneca (Group) | 1991-01-01 |
Cutivate® | corticosteroid_o | GSK (Group) | 1991-01-01 |
Feloc® | calcium channel blocker | AstraZeneca (Group) | 1991-01-01 |
Halfan® | anti-infective drug_o | GSK (Group) | 1991-01-01 |
Halofantrin SmithKline Beecham® | anti-infective drug_o | GSK (Group) | 1991-01-01 |
Lacipil® | calcium channel blocker | GSK (Group) | 1991-01-01 |
Manoplax® | pharmaceutical_oo | Boots Company (Group) | 1991-01-01 |
Optiray® | pharmaceutical_oo | Covidien (Group) | 1991-01-01 |
Plendil® | calcium channel blocker | AstraZeneca (Group) | 1991-01-01 |
Psyloc® | psychopharmaceutical | AstraZeneca (Group) | 1991-01-01 |
Roxiam® | psychopharmaceutical | AstraZeneca (Group) | 1991-01-01 |
Sevredol® | opioid | Purdue Pharma (Group) | 1990-11-14 |
Genotropin® | anterior pituitary lobe hormone or analogue | Pfizer (Group) | 1990-07-01 |
Tagamet® | H2 receptor antagonist | GSK (Group) | 1990-07-01 |
Zantac® | H2 receptor antagonist | GSK (Group) | 1990-07-01 |
Augmentin® | penicillin | GSK (Group) | 1990-01-01 |
AutoSpec™ Ultima mass spectrometer | sector mass spectrometer | Waters (Group) | 1990-01-01 |
Bambuterol® | bronchospasmolytics & asthma drugs_o | AstraZeneca (Group) | 1990-01-01 |
Ceramos® | serotonin antagonist | GSK (Group) | 1990-01-01 |
Deca-Ferring® | cancer drug_o | Ferring (Paulsen Foundation) (Group) | 1990-01-01 |
Dyazide® | antihypertensive drug_o | GSK (Group) | 1990-01-01 |
Flixonase® | pharmaceutical_oo | GSK (Group) | 1990-01-01 |
Foscavir® | anti-infective drug_o | AstraZeneca (Group) | 1990-01-01 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top